Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 7/20 | 0.66 |
| ▸ | RAB9A | P51151 | 7/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.66 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.62 |
| ▸ | BCL2 | P10415 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30021053 | 1.00 | NPC1 (0.66) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL6254969 | 0.98 | NPC1 (0.63) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| Ammonia Solution, Strong SCHEMBL27784024 | 0.98 | NPC1 (0.63) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| Bicarbonate SCHEMBL17747111 | 0.94 | NPC1 (0.59) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL9423354 | 0.94 | CHEK1 (0.65) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL3160291 | 0.94 | ALDH1A1 (0.55) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL17208869 | 0.91 | NPC1 (0.56) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| Acetaldehyde SCHEMBL5981408 | 0.91 | NPC1 (0.61) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL47054 | 0.87 | CHEK1 (0.54) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| Acetic Acid SCHEMBL6288239 | 0.85 | ALDH1A1 (0.54) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119391158-A | Laser color marking composition for black ground color, and preparation method and application thereof | 四川大学 | 2025-02-07 | — | — | CN | claimed |
| CN-118121650-A | Traditional Chinese medicine extract, preparation method thereof and blood component detection method | 川北医学院 | 2024-06-04 | — | — | CN | claimed |
| CN-117683195-A | Anthraquinone modified polyurethane and preparation method and application thereof | 厦门理工学院 | 2024-03-12 | — | — | CN | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| WO-2020126442-A1 | ONE-PART PHOTOCURABLE (METH) ACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-06-25 | — | — | WO | claimed |
| CN-107846904-A | New product | 阿尔法生物农药有限公司 | 2018-03-27 | — | — | CN | claimed |
| CN-106928908-A | A kind of new aeroge multifunctional material and preparation method thereof | 广州市芯检康生物科技有限公司 | 2017-07-07 | — | — | CN | claimed |
| CN-105778404-A | Flame retardant insulation foam material and preparation method thereof | 苏州甫众塑胶有限公司 | 2016-07-20 | — | — | CN | claimed |
| WO-2000066091-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING POLYMERS | BIOTECH AUSTRALIA PTY LIMITED (AU) | 2000-11-09 | — | — | WO | claimed |
| WO-2000066090-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING NANOPARTICLES | BIOTECH AUSTRALIA PTY LIMITED (AU) | 2000-11-09 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0410287-B1 | Polyphosphazene derivatives containing carbonyl groups and variously alkylated tertiary amino groups | CONSIGLIO NAZIONALE RICERCHE (IT) | 1995-11-02 | — | — | EP | claimed |
| EP-0450461-B1 | LHRH Analogs | UNIV TULANE (US) | 1995-09-06 | — | — | EP | claimed |
| US-5064442-A | HAIR DYES | L'OREAL (FR) | 1991-11-12 | — | — | US | claimed |
| EP-0450480-A2 | Somatostatin Analogues | The Administrators of The Tulane Educational Fund (US) | 1991-10-09 | — | — | EP | claimed |
| US-5041524-A | Polyphosphazene derivatives containing carbonyl groups suitable for photoreticulation processes | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1991-08-20 | — | — | US | claimed |
| EP-0410287-A2 | Polyphosphazene derivatives containing carbonyl groups and variously alkylated tertiary amino groups | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1991-01-30 | — | — | EP | claimed |
| EP-0369398-A2 | Polyphosphazene derivatives containing carbonyl groups suitable for photoreticulation processes | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1990-05-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | NPC1 80/4885RAB9A 3373/4885ALDH1A1 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.